The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on July 15, 2026

Jul. 15, 2026

SHAREHOLDER ALERT: GPGI, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton To Learn How They Might Recover Their Losses

Indeterminate GlobeNewswire

Jul. 15, 2026

MDaudit Advances Its Meaningful AI Strategy with the Addition of Auditor Assist to Its Continuous Risk Monitoring Solutions Suite

Indeterminate GlobeNewswire

Jul. 15, 2026

Sophos Launches Sophos Fusion, the Industry’s First and Most Complete AI-Native Cybersecurity Defense System

Indeterminate GlobeNewswire

Jul. 15, 2026

Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman

Indeterminate GlobeNewswire

Jul. 15, 2026

Payscale Labor Market & Wage Trend Report: New Data Shows Labor Market Bifurcation Accelerating as Wage Growth Falls Behind Inflation

Indeterminate GlobeNewswire

Jul. 15, 2026

Cynet Releases v4.33 Unveiling a New Cross-Site Dashboard and Enhanced SIEM Capabilities

Indeterminate GlobeNewswire

Jul. 15, 2026

MIT Sloan School of Management launches Evening MBA

Indeterminate GlobeNewswire

Jul. 15, 2026

Aware Sets Second Quarter 2026 Webcast for Wednesday, July 29, 2026, at 5:00 p.m. Eastern Time

Indeterminate GlobeNewswire

Jul. 15, 2026

Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center

Indeterminate GlobeNewswire

Jul. 15, 2026

Biogen Appoints Michael J. Parini as Chief Legal Officer

Indeterminate GlobeNewswire

Jul. 15, 2026

TWISTED TEA HARD ICED TEA INVENTS THE ONLY FAIR DIVORCE SETTLEMENT IN AMERICA

Indeterminate GlobeNewswire

Jul. 15, 2026

Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry

Indeterminate GlobeNewswire

Jul. 15, 2026

Repligen to Report Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 15, 2026

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

MariMed Announces Second Quarter 2026 Earnings Date

Indeterminate GlobeNewswire

Jul. 15, 2026

BPGbio Reports Encouraging Preliminary Data from Ongoing Phase 2 Study of BPM31510 in Newly Diagnosed Glioblastoma

Indeterminate GlobeNewswire

Jul. 15, 2026

Akamai Research: Commerce Becomes the Epicenter for AI Bot Attacks and Agentic Fraud in 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

79% of Ransomware Attacks Now Originate from Compromised Identities, Sophos Report Finds

Indeterminate GlobeNewswire

Jul. 15, 2026

Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation

Indeterminate GlobeNewswire

Jul. 15, 2026

Epoch Biotech Highlights New Preclinical Data for APOE Christchurch-Mimetic Antibody at AAIC 2026 Demonstrating Favorable PK/PD and Differentiated Biomarker Approach

Indeterminate GlobeNewswire